PI Pharma Insight

Tadomon 25mg prolonged-release tablets

BNF presentation 0407020AGBDAFAI within chapter Central Nervous System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.

Product

Tadomon

Chemical substance

Tapentadol

Presentation code

0407020AGBDAFAI

Usage overview

Total items and spend derived from NHS dispensing data.

Items dispensed

1

NHS spend (£)

£5.54

Recent activity

March 2025

Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.

Dispensing trend

Month-by-month national usage.

Month Items dispensed
March 2025 1

Top pharmacies dispensing this medicine

Identify providers with the highest utilisation to focus engagement and support.